Telehealth’s Rural Reach: Mental Health, GLP-1s & AI in Health Tech

Medicare Telehealth and Mental Health: Access Remains Uneven

The expansion of Medicare telehealth coverage during the pandemic offered a potential solution to longstanding access issues in mental health care, particularly for those in rural and underserved areas. However, a new analysis of Medicare claims data from 2018 through 2023 suggests that the benefits haven’t reached those who need them most. While telehealth adoption has increased significantly, it isn’t substantially increasing the number of patients served in rural communities, raising questions about equitable access and the effectiveness of current policies. This comes as policymakers continue to debate the future of telehealth flexibilities implemented during the public health emergency.

The study, published in JAMA Network Open, examined claims data spanning five years, revealing that mental health providers who readily embraced telehealth weren’t necessarily seeing a corresponding increase in patients from rural or underserved areas. Researchers found that clinicians already operating in areas with high demand were more likely to utilize telehealth to serve their existing communities. This suggests that simply expanding coverage isn’t enough to bridge the gap in access; systemic barriers remain.

The Disparities in Virtual Care

This finding aligns with other recent research highlighting uneven benefits from the surge in virtual mental health care. A 2021 analysis of survey data published in JAMA Psychiatry revealed that individuals with higher incomes, employment and college education were significantly more likely to utilize teletherapy than their counterparts. This underscores the digital divide and socioeconomic factors that can limit access to virtual care, even when it’s available.

The challenges of expanding mental health access to rural communities aren’t new. Efforts to leverage technology for this purpose have been explored for decades. In 2021, STAT reported on a successful pilot program that connected psychiatrists and psychologists in urban centers with remote federally qualified health centers to support primary care providers treating patients with PTSD and bipolar disorder. That initiative highlighted the logistical complexities involved in coordinating such arrangements, demonstrating that simply providing the technology and insurance coverage isn’t sufficient.

Beyond Access: Broadband and Licensing

According to Ateev Mehrotra, a professor at the Brown University School of Public Health and co-author of the recent study, addressing the access gap requires a multi-faceted approach. He suggests that policies focused on increasing broadband access and facilitating interstate licensing for providers could help expand telehealth’s reach. Currently, licensing restrictions often prevent providers from offering services across state lines, limiting the pool of available clinicians in rural areas.

Broadband access remains a significant hurdle. While the Federal Communications Commission (FCC) has programs aimed at expanding broadband infrastructure, particularly in rural areas, progress has been slow and uneven. Without reliable internet connectivity, telehealth remains inaccessible for many potential patients.

GLP-1 Telehealth Operations and Regulatory Scrutiny

The rise of telehealth isn’t limited to mental health. A separate STAT analysis highlights growing concerns surrounding the proliferation of telehealth companies offering compounded GLP-1 medications for obesity and diabetes. The Food and Drug Administration (FDA) is actively cracking down on companies making misleading claims about these drugs, having issued warnings to over 70 companies since last year.

A new STAT investigation reveals that at least 30% of these companies are affiliated with just four nationwide medical groups, often operating as “white label” practices. These groups provide the medical oversight necessary for telehealth businesses to prescribe medications, but the arrangements raise questions about quality control and patient safety. The FDA’s scrutiny is likely to extend to these medical groups as well.

The AI Agent Invasion and Validation Concerns

The integration of artificial intelligence (AI) into healthcare is accelerating, with numerous companies announcing new AI agents at the recent HIMSS conference. These agents are designed to automate tasks such as medical coding, documentation, and scheduling. However, this rapid adoption is raising concerns about the lack of validation and patient input in the development and implementation of these technologies.

As Casey Ross reports, two recent studies are exploring these concerns, highlighting the need for rigorous testing and patient engagement before widespread adoption of AI in healthcare. The potential benefits of AI are significant, but it’s crucial to ensure that these technologies are safe, effective, and equitable.

Health Tech News Roundup

Beyond these key developments, several other noteworthy events are shaping the health tech landscape:

• Omada, a digital health company, posted its first profitable quarter, driven in part by its strategy around GLP-1 medications and AI.
• Google is conducting a randomized study of its experimental clinical AI, AMIE, with Included Health, following a pre-print study showing promising diagnostic accuracy.
• Amigo AI, a developer of patient-facing clinical AI agents, raised $11 million in Series A funding.
• Samsung is partnering with B.well to develop health records readily available on Samsung smartphones.
• Codoxo, a company focused on fraud detection, announced “deepfake detection” capabilities to identify manipulated medical documentation.
• Sword Health expanded its offerings to include AI-powered mental health and cardiometabolic care.
• EHR vendor Meditech added ambient listening capabilities to its mobile apps.
• Video conferencing service Zoom added new healthcare-focused features, including better integration with Epic.
• Revenue management company R1 has a new deal with AI scribe company Heidi Health.

The ongoing evolution of health technology presents both opportunities and challenges. While telehealth and AI hold immense promise for improving access and efficiency, it’s crucial to address the systemic barriers that prevent equitable distribution of these benefits. Continued research, policy adjustments, and a focus on patient-centered design will be essential to realizing the full potential of these innovations.

Looking ahead, further investigation into the factors driving disparities in telehealth access is needed. Policymakers will likely continue to evaluate the long-term impact of pandemic-era telehealth flexibilities and consider permanent changes to regulations. Ongoing monitoring of the FDA’s enforcement actions related to GLP-1 telehealth operations will similarly be critical. And as AI becomes increasingly integrated into healthcare, rigorous validation studies and patient engagement will be paramount to ensuring safe and effective implementation.